معرفی
Professor Nigel Brunskill is a Professor of Renal Medicine and Consultant Nephrologist at the University of Leicester, leading the Leicestershire Academic Health Partners (LAHP) and serving as the University's Clinical Research Lead. His roles include directing the NIHR Leicester Clinical Research Facility and co-chairing the UK Kidney Research Consortium's Chronic Kidney Disease Clinical Study Group. His research focuses on chronic kidney disease (CKD), fibrosis inhibition, and pandemic-related health outcomes, with significant contributions to trials like the RECOVERY trial evaluating treatments for hospitalized COVID-19 patients. He also leads initiatives addressing long-term post-COVID-19 health impacts through studies like PHOSP-COVID.
His academic affiliations include the University of Leicester's Department of Cardiovascular Sciences, University Hospitals Leicester NHS Trust, and collaborations with the Leicestershire Partnership NHS Trust. Research interests span kidney disease pathophysiology, health economics of renal therapies, and translational medicine bridging clinical practice with research innovation. Notable projects include the EMPA-KIDNEY trial investigating empagliflozin's effects and studies on plasma exchange in vasculitis management.
Publications highlight his focus on fibrosis mechanisms, corticosteroid therapies in critical care, and long-term outcomes of hospitalization for severe illnesses. He emphasizes multi-institutional partnerships to accelerate healthcare improvements, exemplified by Leicester’s rapid adaptation during the pandemic. His work bridges nephrology with broader clinical research, emphasizing evidence-based practice and patient-centered methodologies.
